Filana Therapeutics

FLNA

Market cap $43.8M

FLNA Hedge Fund Activity: Q1 2026 in Review

101 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q1 2026, worth a combined $23.1M — down 16% from $27.3M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of FLNA and 15 opened new positions — a net loss of 4 holders — while 37 trimmed existing stakes and 17 added.

The largest buyer was Two Sigma Investments, adding an estimated $2.77M. The largest seller was Jane Street, cutting an estimated $593K.

• 101 institutional investors held Filana Therapeutics (FLNA) as of Q1 2026, down from 107 in Q4 2025.
• Funds reported $23.1M of Filana Therapeutics stock for Q1 2026, down 16% quarter-over-quarter.
• 15 funds opened new Filana Therapeutics positions in Q1 2026 and 19 closed out, a net change of -4 holders.
• The largest Filana Therapeutics buyer in Q1 2026 was Two Sigma Investments, an estimated $2.77M added.
• The largest Filana Therapeutics seller in Q1 2026 was Jane Street, an estimated $593K sold.

Based on aggregated 13F filings for Q1 2026.